Triplex-forming MicroRNAs form stable complexes with HIV-1 provirus and inhibit its replication

Applied Immunohistochemistry and Molecular Morphology

Volumn 18, Issue 6, 2010, Pages 532-545

  Kanak, Mazhar ^a   Alseiari, Mohammed ^b   Balasubramanian, Prathap ^a   Addanki, Krishna ^a   Aggarwal, Mayank ^a   Noorali, Samina ^b   Kalsum, Azima ^a   Mahalingam, Kuha ^b   Pace, Gene ^b   Panasik, Nicholas ^a   Bagasra, Omar ^a  

^a South Carolina Center for Biotechnology   (United States)

^b CLAFLIN UNIVERSITY   (United States)

Author keywords

HIV; microRNA; mRNA; triplex forming miRNA; Vaccine

Indexed keywords

ANTIGEN P24; DOUBLE STRANDED RNA; MESSENGER RNA; MICRORNA;

ANTIVIRAL ACTIVITY; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DNA HELIX; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE CONTROL; GENETIC STABILITY; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; VIRUS GENOME; VIRUS REPLICATION;

ALGORITHMS; BASE SEQUENCE; CELL LINE, TUMOR; DATABASES, GENETIC; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION REGULATION; HIV INFECTIONS; HIV-1; HUMANS; MICRORNAS; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDES; RNA, VIRAL; T-LYMPHOCYTES; VIRUS LATENCY; VIRUS REPLICATION;

EID: 78650512645     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e3181e1ef6a     Document Type: Article

References (53)

1. Franklin RE, Gosling RG. Evidence for 2-chain helix in crystalline structure of sodium deoxyribonucleate. Nature. 1953;172:156-157.
2. Watson JD, Crick FH. Molecular structure of nucleic acids; a structure for deoxyribose nucleic acid. Nature. 1953;171:737-738.
3. Hoogsteen K. The structures of crystals containing a hydrogen complex bonding of 1-methylthymine and 9-methyladenine. Acta Cryst. 1959;12:822-823.
4. Wilkins MH, Stokes AR, Wilson HR. Molecular structure of deoxypentose nucleic acids. Nature. 1953;171:738-740.
5. Felsenfeld G, Davies DR, Rich A. Formation of a three-stranded polynucleotide molecule. J Am Chem Soc. 1957;79:2023.
6. Morgan AR, Wells RD. Specificity of the three-stranded complex formation between double stranded DNA and single-stranded RNA containing repeating nucleotide sequences. J Mol Biol. 1968;37: 63-80.
7. Goni JR, de la Cruz X, Orozco M. Triplex-forming oligonucleotide target sequences in the human genome. Nucleic Acids Res. 2004;32: 354-360. (Pubitemid 38228635)
8. Goni JR, Vaquerizas JM, Dopazo J, et al. Exploring the reasons for the large density of triplex-forming oligonucleotide target sequences in the human regulatory regions. BMC Genomics. 2006;7:63.
9. Mahalingam K, Bagasra O. Bioinformatics Tools: Searching for Markers in DNA/RNA Sequences. Biocomp. Vol II. Proceedings of Computer Science Computer Engineering and Applied Computing. Los Vegas, NV: 2008:612-615.
10. Bagasra O. A unified concept of HIV-1 Latency. Expert Opin Biol Ther. 2006;6:1135-1149.
11. Christiansen ME, Znosko BM. Thermodynamic characterization of the complete set of sequence symmetric tandem mismatches in RNA and an improved model for predicting the free energy contribution of sequence asymmetric tandem mismatches. Biochemistry. 2008;47: 4329-4336.
12. Bagasra O, Stir AE, Pirisi-Creek L, et al. Role of miRNAs in regulation of lentiviral latency and persistence. Appl Immunohistochem Mol Morphol. 2006;14:276-290. (Pubitemid 44319053)
13. Griffiths-Jones S, Saini HK, Van Dongen S, et al. miRBase: tools for microRNA genomics. Nucleic Acids Res. 2008;236:D154-D158. (Pubitemid 351149713)
14. Hakim ST, Alsayari M, McLean DC, et al. A large number of the primate microRNAs target lentiviruses, RE and endogenous retroviruses. Biochem Biophys Res Commun. 2008;369:357-362.
15. James PL, Brown T, Fox KR. Thermodynamic and kinetic stability of intermolecular triple helices containing different proportions of C+*GC and T*AT triplets. Nucleic Acids Res. 2003;3:5598-5606. (Pubitemid 37441931)
16. Martianov I, Ramadass A, Serra Barros A, et al. Repression of the human dihydrofolate reductase gene by a non-coding interfering transcript. Nature. 2007;445:666-670. (Pubitemid 46232888)
17. Bagasra O, Whittle P, Heins B, et al. Anti-HIV-1 activity of sulfated monosaccharides: comparison with sulfated polysaccharides and other polyions. J Infect Dis. 1991;164:1082-1090.
18. Bagasra O. Protocols for the in situ PCR-amplification and detection of mRNA and DNA sequences. Nat Protoc. 2007;2:z2782-2795.
19. Agazie YM, Burkholder GD, Lee JS. Triplex DNA in the nuclus: direct binding of triplex specific antibodies and their effect on transcription, replication and cell growth. Biochem J. 1996;316:461-466.
20. Nuovo G, Lee EJ, Lawler S, et al. In situ detection of mature microRNAs by labeled extension on ultramer templates. Biotechniques. 2009;46:115-126.
21. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281-297.
22. Kurreck J. RNA interference: from basic research to therapeutic applications. Angew Chem Int Ed Engl. 2009;48:1378-1398.
23. Obbard DJ, Gordon KH, Buck AH, et al. The evolution of RNAi as a defence against viruses and transposable elements. Philos Trans R Soc Lond B Biol Sci. 2009;364:99-115.
24. Roberts RW, Crothers DM. Prediction of the stability of DNA triplexes. Proc Natl Acad Sci U S A. 1996;93:4320-4325.
25. Vasquez KM, Narayanan L, Glazer PM. Specific mutations induced by triplex-forming oligonucleotides in mice. Science. 2000;290:530-533.
26. Beal PA, Dervan PB. Second structural motif for recognition of DNA by oligonucleotide-directed triple-helix formation. Science. 1991;251:1360-1363. (Pubitemid 21916920)
27. Duca M, Vekhoff P, Oussedik K, et al. The triplex helix: 50 years later, the outcome. Nucleic Acids Res. 2008;16:5123-5138.
28. Wang YP, Li KB. Correlation of expression profiles between microRNAs and mRNAtargets using NCI-60 data. BMC Genomics. 2009;10:218-231.
29. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120:15-20.
30. Grimson A, Farh KK, Johnston WK, et al. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell. 2007;27:91-105. (Pubitemid 46991392)
31. Matzke MA, Mette MF, Matzke AJ. Transgene silencing by the host genome defense: implications for the evolution of epigenetic control mechanisms in plants and vertebrates. Plant Mol Biol. 2000; 43:401-415.
32. Taganov KD, Boldin MP, Baltimore D. MicroRNAs and immunity: tiny players in a big field. Immunity. 2007;2:133-137. (Pubitemid 46329443)
33. Cullen BR. Viruses and microRNAs. Nat Genet. 2006;38:S25-S30. (Pubitemid 43920940)
34. Lecellier CH, Dunoyer P, Arar K, et al. A cellular microRNA mediates antiviral defense in human cells. Science. 2005;308:557-560. (Pubitemid 40570587)
35. Bramsen JB, Laursen MB, Damgaard CK, et al. Improved silencing properties using small internally segmented interfering RNAs. Nucleic Acids Res. 2007;35:5886-5897. (Pubitemid 47506303)
36. Raghavan SC, Chastain P, Lee JS, et al. Evidence for a triplex DNA conformation at the bcl-2 major breakpoint region of the t(14;18) translocation. J Biol Chem. 2005;280:22749-22760. (Pubitemid 40853180)
37. Letai AG, Palladino MA, Fromm E, et al. Specificity in formation of triple-stranded nucleic acid helical complexes: studies with agarose linked polyribonucleotide affinity columns. Biochemistry. 1988; 27:9108-9112.
38. Carbone GM, McGuffie EM, Collier A, et al. Selective inhibition of transcription of the Ets2 gene in prostate cancer cells by a triplexforming oligonucleotide. Nucleic Acids Res. 2003;31:833-843. (Pubitemid 36240421)
39. Marck C, Thiele D. Poly(dG).poly(dC) at neutral and alkaline pH: the formation of triple stranded poly(dG).poly(dG).poly(dC). Nucleic Acids Res. 1978;5:1017-1028. (Pubitemid 8291152)
40. Westerhout EM, Ooms M, Vink M, et al. HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome. Nucleic Acids Res. 2005;33:796-804. (Pubitemid 40361009)
41. Krom YD, Fallaux FJ, Que I, et al. Efficient in vivo knock-down of estrogen receptor alpha: application of recombinant adenovirus vectors for delivery of short hairpin RNA. BMC Biotechnol. 2006;6:11.
42. Bennasser Y, Le SY, Benkirane M, et al. Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. Immunity. 2005;22:607-619. (Pubitemid 40719196)
43. Saetrom P, Heale BS, Snove O Jr, et al. Distance constraints between microRNA target sites dictate efficacy and cooperativity. Nucleic Acids Res. 2007;35:2333-2342. (Pubitemid 47073716)
44. Brown KM, Chu CY, Rana TM. Target accessibility dictates the potency of human RISC. Nat Struct Mol Biol. 2005;12:469-470.
45. Huang J, Wang F, Argyris E, et al. Cellular microRNAs contribute to HIV-1 latency in resting primary CD4(+) T lymphocytes. Nat Med. 2007;13:1241-1247. (Pubitemid 47530631)
46. Houzet L, Yeung ML, de Lame V, et al. MicroRNA profile changes in human immunodeficiency virus type 1 (HIV-1) seropositive individuals. Retrovirology. 2008;5:118.
47. Liu YP, Gruber J, Haasnoot J, et al. RNAi-mediated inhibition of HIV-1 by targeting partially complementary viral sequences. Nucleic Acids Res. 2009;37:6194-6204.
48. Siliciano JD, Kajdas J, Finzi D, et al. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nat Med. 2003;9:727-728. doi: 10.1038/nm880. (Pubitemid 36749221)
49. Lehrman G, Hogue IB, Palmer S, et al. Depletion of latent HIV-1 infection in vivo: a proof-of-concept study. Lancet. 2005;366: 549-555. doi: 10.1016/S0140-6736(05)67098-5. (Pubitemid 41140329)
50. Findi D, Blackson J, Siliciano JD et al. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med. 1999;5: 512-517.
51. Chun TW, Carruth L, Findi D, et al. Quantitation of latent tissue reservoirs and total body load in HIV-1 infection. Nature. 1997;387: 183-188. (Pubitemid 27209433)
52. Bagasra O, Wright SD, Seshamma T, et al. CD14, a lipopolysaccharide receptor is involved with the control of human immunodeficiency virus type 1 HIV-1 expression in latently-infected cells. Proc Natl Acad Sci U S A. 1992;89:6285-6289.
53. Cohen J. HIV natural resistance field finally overcomes resistance. Science. 2009;326:1476-1477.